Circular Polarized Light Emission in Chiral Inorganic Nanomaterials
Overview
Authors
Affiliations
Chiral inorganic nanostructures strongly interact with photons changing their polarization state. The resulting circularly polarized light emission (CPLE) has cross-disciplinary importance for a variety of chemical/biological processes and is essential for development of chiral photonics. However, the polarization effects are often complex and their interpretation is dependent on the several structural parameters of the chiral nanostructure. CPLE in nanostructured media has multiple origins and several optical effects are typically convoluted into a single output. Analyzing CPLE data obtained for nanoclusters, nanoparticles, nanoassemblies, and nanocomposites from metals, chalcogenides, perovskite, and other nanostructures, it is shown here that there are several distinct groups of nanomaterials for which CPLE is dominated either by circularly polarized luminescence (CPL) or circularly polarized scattering (CPS); there are also many nanomaterials for which they are comparable. The following points are also demonstrated: 1) CPL and CPS contributions involve light-matter interactions at different structural levels; 2) contribution from CPS is especially strong for nanostructured microparticles, nanoassemblies, and composites; and 3) engineering of materials with strongly polarized light emission requires synergistic implementation of CPL and CPS effects. These findings are expected to guide development of CPLE materials in a variety of technological fields, including 3D displays, information storage, biosensors, optical spintronics, and biological probes.
Wang Z, Wang Q, Quan L, Ren S Adv Sci (Weinh). 2025; 12(10):e2414977.
PMID: 39836605 PMC: 11905069. DOI: 10.1002/advs.202414977.
Green Synthesis of Biocompatible Chiral Gold Nanoparticles.
Fan Y, Li N, Wang J, Liao L, Wei J Polymers (Basel). 2024; 16(23).
PMID: 39684078 PMC: 11644158. DOI: 10.3390/polym16233333.
Considering the impact of the chirality of therapeutic nanoparticles on cancer therapy.
Wang S, Li L Nanomedicine (Lond). 2024; 19(28):2331-2334.
PMID: 39316556 PMC: 11492700. DOI: 10.1080/17435889.2024.2403320.
Li S, Tang Y, Fan Q, Li Z, Zhang X, Wang J Light Sci Appl. 2024; 13(1):140.
PMID: 38876989 PMC: 11178798. DOI: 10.1038/s41377-024-01479-1.
Emerging trends in chiral inorganic nanomaterials for enantioselective catalysis.
Li S, Xu X, Xu L, Lin H, Kuang H, Xu C Nat Commun. 2024; 15(1):3506.
PMID: 38664409 PMC: 11045795. DOI: 10.1038/s41467-024-47657-y.